B. Metzler seel. Sohn & Co. AG Purchases New Shares in Danaher Corporation $DHR

B. Metzler seel. Sohn & Co. AG acquired a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, HoldingsChannel.com reports. The fund acquired 92,424 shares of the conglomerate’s stock, valued at approximately $17,605,000.

A number of other hedge funds have also recently modified their holdings of the company. High Note Wealth LLC lifted its position in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. raised its stake in Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares in the last quarter. GW&K Investment Management LLC lifted its stake in Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares during the last quarter. Finally, SOL Capital Management CO boosted its stake in Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $219.42 on Friday. The business has a fifty day simple moving average of $195.80 and a 200-day simple moving average of $192.61. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the firm posted $0.77 earnings per share. The firm’s revenue was up 5.5% on a year-over-year basis. As a group, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Ratings Changes

DHR has been the subject of several recent research reports. Argus decreased their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Stifel Nicolaus dropped their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.